Hiv Vaccine Trials Network

This early-stage study tested the safety and immune response of an experimental HIV vaccine in healthy infants born to mothers with HIV. The study enrolled 38 mother-infant pairs, with infants receiving up to five vaccine doses starting in their first week of life. The main goals…

This early-stage study tested the safety and immune response of a new experimental HIV vaccine in healthy adults. Thirty-four participants received either the vaccine or a placebo to see if it was well-tolerated and could trigger an immune defense against HIV. The goal was to gat…

This study tested whether people who received an experimental antibody (VRC01) before getting HIV could better control the virus without needing daily medication. Thirteen participants who had been taking HIV drugs for at least a year temporarily stopped their medication under ve…

This study aimed to understand how the body's immune system responds after recovering from a SARS-CoV-2 infection, which causes COVID-19. Researchers enrolled 760 adults who had previously tested positive for the virus and followed them for up to a year. By taking blood and nasal…